Research institutional investors rely on
Professional valuation models, three-scenario analysis, and primary research through channel checks with customers, competitors, and experts. We uncover dynamics before the market does.
FACILITATED INVESTMENT PROCESS FOR PROFESSIONALS
Get direct access to analysts and company management + structured analysis on 146 Nordic growth companies—with our Quality-First Framework, insider signals, and analyst team insights most investors never see.
Contact us
- Trusted by institutional investors since 1999
- 2,100+ reports annually
The Redeye Advantage
Nordic mid-cap Tech and Life Science companies offer extraordinary growth potential—but deep research is scarce. Redeye's Quality First methodology fills this gap. Our 100+ point checklist evaluates People, Business, and Financials across 170+ companies. The result: high-rated companies consistently deliver superior alpha.
Direct access to the market
Direct analyst contact, facilitated management meetings at 146 companies, and 100+ annual events including our exclusive Serial Acquirers Club.
Proprietary intelligence tools
Quality Rating filters, Top Picks portfolio, ownership analytics, momentum data, and short interest tracking in one integrated platform.
“Redeye are different to other research providers. They are truly long-term focused and think like investors.”
Andrew Strasser, Investment Analyst at Constantia Investment Partners, Australia
Built on Fundamentals, Proven by Results
Our analysts don't rely on consensus estimates or surface-level metrics. We systematically evaluate what truly drives long-term returns—management quality, competitive moats, and financial durability. This disciplined approach consistently identifies opportunities before they're priced in.
Quality First Framework
Our systematic approach evaluates 100+ factors across three pillars. Management quality, compensation alignment, innovation capacity, balance sheet health, competitive positioning—nothing escapes our checklist.
Primary Research Advantage
Our analysts conduct field research: customer interviews, supplier checks, competitor analysis, industry expert consultations. We piece together non-material information to form material conclusions before the market catches on.
Valuation Rigor
Scenario-based DCF, peer analysis, and sum-of-the-parts models for every company. Three distinct outcomes help you understand risk-reward with precision.
Years of Nordic market expertise
Companies under deep coverage
Research reports annually
Management Video Interviews
What's Included
Platform Access
Make Faster Decisions
→
Full research archive on all 146 covered companies
→
Proprietary Quality Rating (People, Business, Financials)
→
Quarterly theme reports (Serial Acquirers, SaaS, IT Consulting)
→
Annual sector outlooks (Gaming, Cybersecurity, Life Science)
→
Same-day earnings notes + next-day deep updates
Direct Access
Get Expert Answers
→
Analyst contact for your research questions
→
Corporate access to management teams
→
Priority invitations to in-person conferences
→
Exclusive Serial Acquirers Club membership
→
Priority customer support
Digital Intelligence
Spot Opportunities Early
→
Stock screener with Quality Rating filters
→
Top Picks portfolio (live updates)
→
Ownership, Dividend & Momentum analytics
→
Custom notification system
→
Fund & insider ownership data
→
Short interest tracking
QUARTERLY
37,500 SEK
per quarter excl. VAT and taxes.
ANNUAL
150,000 SEK
annually excl. VAT and taxes.
Schedule a consultation
Meet Your Research Team
Our 30+ analysts bring deep sector expertise across Technology and Life Science. From ex-traders at East Capital to PhDs in molecular biology, from former entrepreneurs to CFA charterholders—each brings unique perspectives to fundamental analysis.
View the full team
Book a briefing
Mäster Samuelsgatan 42, 10th floor
Box 7141, 103 87
Stockholm, Sweden
info@redeye.se+46 (0)8 545 013 30
REDEYE CAPITAL
FACILITATED INVESTMENT PROCESS FOR PROFESSIONALS
Get direct access to analysts and company management + structured analysis on 146 Nordic growth companies—with our Quality-First Framework, insider signals, and analyst team insights most investors never see.
Contact us
- Trusted by institutional investors since 1999
- 2,100+ reports annually
The Redeye Advantage
Nordic mid-cap Tech and Life Science companies offer extraordinary growth potential—but deep research is scarce. Redeye's Quality First methodology fills this gap. Our 100+ point checklist evaluates People, Business, and Financials across 170+ companies. The result: high-rated companies consistently deliver superior alpha.
Research institutional investors rely on
Professional valuation models, three-scenario analysis, and primary research through channel checks with customers, competitors, and experts. We uncover dynamics before the market does.
Direct access to the market
Direct analyst contact, facilitated management meetings at 146 companies, and 100+ annual events including our exclusive Serial Acquirers Club.
Proprietary intelligence tools
Quality Rating filters, Top Picks portfolio, ownership analytics, momentum data, and short interest tracking in one integrated platform.
“Redeye are different to other research providers. They are truly long-term focused and think like investors.”
Andrew Strasser, Investment Analyst at Constantia Investment Partners, Australia
Built on Fundamentals, Proven by Results
Our analysts don't rely on consensus estimates or surface-level metrics. We systematically evaluate what truly drives long-term returns—management quality, competitive moats, and financial durability. This disciplined approach consistently identifies opportunities before they're priced in.
Quality First Framework
Our systematic approach evaluates 100+ factors across three pillars. Management quality, compensation alignment, innovation capacity, balance sheet health, competitive positioning—nothing escapes our checklist.
Primary Research Advantage
Our analysts conduct field research: customer interviews, supplier checks, competitor analysis, industry expert consultations. We piece together non-material information to form material conclusions before the market catches on.
Valuation Rigor
Scenario-based DCF, peer analysis, and sum-of-the-parts models for every company. Three distinct outcomes help you understand risk-reward with precision.
Years of Nordic market expertise
Companies under deep coverage
Research reports annually
Management Video Interviews
What's Included
Platform Access
Make Faster Decisions
→
Full research archive on all 146 covered companies
→
Proprietary Quality Rating (People, Business, Financials)
→
Quarterly theme reports (Serial Acquirers, SaaS, IT Consulting)
→
Annual sector outlooks (Gaming, Cybersecurity, Life Science)
→
Same-day earnings notes + next-day deep updates
Direct Access
Get Expert Answers
→
Analyst contact for your research questions
→
Corporate access to management teams
→
Priority invitations to in-person conferences
→
Exclusive Serial Acquirers Club membership
→
Priority customer support
Digital Intelligence
Spot Opportunities Early
→
Stock screener with Quality Rating filters
→
Top Picks portfolio (live updates)
→
Ownership, Dividend & Momentum analytics
→
Custom notification system
→
Fund & insider ownership data
→
Short interest tracking
QUARTERLY
37,500 SEK
per quarter excl. VAT and taxes.
ANNUAL
150,000 SEK
annually excl. VAT and taxes.
Schedule a consultation
Meet Your Research Team
Our 30+ analysts bring deep sector expertise across Technology and Life Science. From ex-traders at East Capital to PhDs in molecular biology, from former entrepreneurs to CFA charterholders—each brings unique perspectives to fundamental analysis.
View the full team
Book a briefing
REDEYE CAPITAL
Mäster Samuelsgatan 42, 10th floor
Box 7141, 103 87
Stockholm, Sweden
info@redeye.se+46 (0)8 545 013 30
FACILITATED INVESTMENT PROCESS FOR PROFESSIONALS
Get direct access to analysts and company management + structured analysis on 146 Nordic growth companies—with our Quality-First Framework, insider signals, and analyst team insights most investors never see.
Contact us
- Trusted by institutional investors since 1999
- 2,100+ reports annually
The Redeye Advantage
Nordic mid-cap Tech and Life Science companies offer extraordinary growth potential—but deep research is scarce. Redeye's Quality First methodology fills this gap. Our 100+ point checklist evaluates People, Business, and Financials across 170+ companies. The result: high-rated companies consistently deliver superior alpha.
Research institutional investors rely on
Professional valuation models, three-scenario analysis, and primary research through channel checks with customers, competitors, and experts. We uncover dynamics before the market does.
Direct access to the market
Direct analyst contact, facilitated management meetings at 146 companies, and 100+ annual events including our exclusive Serial Acquirers Club.
Proprietary intelligence tools
Quality Rating filters, Top Picks portfolio, ownership analytics, momentum data, and short interest tracking in one integrated platform.
“Redeye are different to other research providers. They are truly long-term focused and think like investors.”
Andrew Strasser, Investment Analyst at Constantia Investment Partners, Australia
Built on Fundamentals, Proven by Results
Our analysts don't rely on consensus estimates or surface-level metrics. We systematically evaluate what truly drives long-term returns—management quality, competitive moats, and financial durability. This disciplined approach consistently identifies opportunities before they're priced in.
Quality First Framework
Our systematic approach evaluates 100+ factors across three pillars. Management quality, compensation alignment, innovation capacity, balance sheet health, competitive positioning—nothing escapes our checklist.
Primary Research Advantage
Our analysts conduct field research: customer interviews, supplier checks, competitor analysis, industry expert consultations. We piece together non-material information to form material conclusions before the market catches on.
Valuation Rigor
Scenario-based DCF, peer analysis, and sum-of-the-parts models for every company. Three distinct outcomes help you understand risk-reward with precision.
Years of Nordic market expertise
Companies under deep coverage
Research reports annually
Management Video Interviews
What's Included
Platform Access
Make Faster Decisions
→
Full research archive on all 146 covered companies
→
Proprietary Quality Rating (People, Business, Financials)
→
Quarterly theme reports (Serial Acquirers, SaaS, IT Consulting)
→
Annual sector outlooks (Gaming, Cybersecurity, Life Science)
→
Same-day earnings notes + next-day deep updates
Direct Access
Get Expert Answers
→
Analyst contact for your research questions
→
Corporate access to management teams
→
Priority invitations to in-person conferences
→
Exclusive Serial Acquirers Club membership
→
Priority customer support
Digital Intelligence
Spot Opportunities Early
→
Stock screener with Quality Rating filters
→
Top Picks portfolio (live updates)
→
Ownership, Dividend & Momentum analytics
→
Custom notification system
→
Fund & insider ownership data
→
Short interest tracking
QUARTERLY
37,500 SEK
per quarter excl. VAT and taxes.
ANNUAL
150,000 SEK
annually excl. VAT and taxes.
Schedule a consultation
Meet Your Research Team
Our 30+ analysts bring deep sector expertise across Technology and Life Science. From ex-traders at East Capital to PhDs in molecular biology, from former entrepreneurs to CFA charterholders—each brings unique perspectives to fundamental analysis.
View the full team
Book a briefing
Mäster Samuelsgatan 42, 10th floor
Box 7141, 103 87
Stockholm, Sweden
info@redeye.se+46 (0)8 545 013 30
REDEYE CAPITAL